Akcie v oběhu společnosti Beam Therapeutics
Jaká je hodnota metriky Akcie v oběhu společnosti Beam Therapeutics?
Hodnota metriky Akcie v oběhu společnosti Beam Therapeutics Inc. je 54.087M 79.38%
Jaká je definice metriky Akcie v oběhu?
Akce v oběhu (Shares float) je podíl akcií společnosti vlastněných veřejnými investory vůči zablokovaným akcím (nejsou volně v oběhu).
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
Akcie v oběhu společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Beam Therapeutics
Čemu se věnuje společnost Beam Therapeutics?
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Firmy s metrikou akcie v oběhu podobnou společnosti Beam Therapeutics
- Hodnota metriky Akcie v oběhu společnosti ASOS Plc je 53.982M 54.01%
- Hodnota metriky Akcie v oběhu společnosti ASOS Plc je 53.982M 54.01%
- Hodnota metriky Akcie v oběhu společnosti Sino Gas je 54.000M 25.00%
- Hodnota metriky Akcie v oběhu společnosti TAO Commodities je 54.001M 172.05%
- Hodnota metriky Akcie v oběhu společnosti India Steel Works je 54.008M 13.57%
- Hodnota metriky Akcie v oběhu společnosti Computer And Technologies je 54.062M 21.67%
- Hodnota metriky Akcie v oběhu společnosti Beam Therapeutics je 54.087M 79.38%
- Hodnota metriky Akcie v oběhu společnosti Whirlpool je 54.090M 89.05%
- Hodnota metriky Akcie v oběhu společnosti Whirlpool je 54.090M 84.77%
- Hodnota metriky Akcie v oběhu společnosti Majestic Wine Plc je 54.092M 73.66%
- Hodnota metriky Akcie v oběhu společnosti Cache Exploration je 54.099M 104.77%
- Hodnota metriky Akcie v oběhu společnosti Petrox Resources je 54.111M 98.15%
- Hodnota metriky Akcie v oběhu společnosti CannPal Animal Therapeutics je 54.118M 58.11%